Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

NCT04220970 is registered in ClinicalTrials.gov with The Lymphoma Academic Research Organisation as lead sponsor.

NCT NCT04220970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Lead sponsor
The Lymphoma Academic Research Organisation
Phase
Observational
Overall status
Recruiting
Start date
June 7, 2017
Completion date
June 7, 2032
Enrollment
150 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic large cell lymphoma associated with breast implants (bia-alcl)